Unaffected genetic testing in families at risk of phaeochromocytoma or paraganglioma
Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Scott Akker, Mufaddal Moonim, Paul Carroll(Guy's and St Thomas' NHS Foundation Trust), Ajith Kumar(Great Ormond Street Hospital), Ben Whitelaw, Audrey Jacques(Guy's and St Thomas' NHS Foundation Trust), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Rupert Obholzer(Guy's and St Thomas' NHS Foundation Trust), Barbara McGowan(Guy's and St Thomas' NHS Foundation Trust)
Cited by 0
Related Papers
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Germline mutations in RAD51D confer susceptibility to ovarian cancer
|Nature Genetics|2011|545
Appetite control
|Journal of Endocrinology|2005|431